Spectral AI, Inc.

NASDAQ:MDAI

Medical - Devices

Healthcare
$1.57 +0.28%

+$0.01 today

Market cap
$50.53M
Beta
1.15
P/E (TTM)
-4.0
EPS (TTM)
-$0.45
52W Low $1.18High $3.21

Volume 0.07M

Average 1.00M

MDAI Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Spectral AI, Inc.NASDAQ: MDAI

Net Debt · Q1 FY2026 · quarter ended Mar 2026

Net debt remains negative

Q1 FY2026 net debt was -$1.72M, compared with -$4.31M a year earlier.

Context

  • Net debt amounted to 9.7% of total assets at the end of Q1 FY2026, down 11.1 pp from a year earlier.
  • Net debt grew in size in 1 of the last 3 fiscal years.

What to watch

Whether net debt keeps rising in the next quarterly balance sheet after a +60.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.72M+67.6% QoQ
Last fiscal yearDec 2025
-$5.3M-1034.9% YoY
Year agoMar 2025
-$4.31M+60.1% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+60.1%——
1 year-1034.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
(5.3M) USD
Year-over-year change
-1034.9%

Net Debt vs competitors

How MDAI compares with its peers on the latest reported figures

  • MDAI's Mar 2026 net debt of -$1.72M is the 4th highest of the 9 companies compared; the peer median is -$4.07M.
  • Its year-over-year change of +60.1% is the 3rd highest of 9, against a peer median of -67.4%.
  • Net debt amounts to 9.7% of total assets for MDAI, versus a peer median of 39.3%.
MDAI Competitors Peer median
Net Debt for MDAI and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
KPTIKaryopharm Therapeutics Inc.Mar 2026$140.02M -5.3%+58.0%106.5%
TELATELA Bio, Inc.Jun 2026$26.19M +278.2%—43.8%
ECORelectroCore, Inc.Mar 2026$4.63M +1038.3%—29.9%
MDAISpectral AI, Inc.Mar 2026-$1.72M +60.1%—9.7%
IPSCCentury Therapeutics, Inc.Mar 2026-$3.02M -473.2%—0.9%
COEPCoeptis Therapeutics, Inc.Mar 2026-$5.11M -129.4%—25.8%
TELOTelomir Pharmaceuticals, Inc. Common StockMar 2026-$5.36M -1630.7%—92.5%
SRTSSensus Healthcare, Inc.Mar 2026-$17.92M +2.7%—34.8%
EQEquillium, Inc.Mar 2026-$60.63M -326.8%—96.1%
Peer median (excluding MDAI) -$4.07M-67.4%+58.0%39.3%

Competitors are the stored peer set for MDAI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents16.12M14.17M4.79M5.16M15.39M
Short-term Investments00000
Net Receivables1.51M2.91M2.35M2.51M1.27M
Inventory00230K425K838K
Other Current Assets526.88K270K1.08M746K1.13M
Total Current Assets18.47M17.69M9.9M10.12M19.45M
Property, Plant & Equipment (Net)32K1.03M790K1.97M1.67M
Goodwill00000
Intangible Assets00000
Long-term Investments253.03M4.63M000
Tax Assets00000
Other Non-current Assets(252.99M)(4.63M)00287K
Total Non-current Assets72K1.03M790K1.97M1.95M
Total Assets18.54M18.72M10.69M12.1M21.41M
Account Payables1.41M2.76M2.68M4.04M3.01M
Short-term Debt583K175K436K2.79M2.85M
Tax Payables246K110K107K188K0
Deferred Revenue23K02.31M960K154K
Other Current Liabilities1.14M129K1.82M6.64M11.87M
Total Current Liabilities4.79M6.37M12.4M17.64M20.63M
Long-term Debt00006.51M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities19M0000
Total Non-current Liabilities19M346K01.7M6.51M
Total Liabilities4.79M6.72M12.4M19.35M27.13M
Common Stock135K1K2K2K3K
Retained Earnings(9.02M)(11.93M)(32.79M)(48.1M)(55.8M)
Accumulated OCI0012K3K40K
Other Stockholders Equity00000
Minority Interest00000
Total Equity13.75M12M(1.71M)(7.25M)(5.73M)
Total Debt583K1.2M1.29M4.69M10.09M
Net Debt(15.54M)(12.97M)(3.5M)(467K)(5.3M)

Spectral AI, Inc.

NASDAQ:MDAI

Intrinsic Alpha fair value

Locked

Current Price

$1.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.